Research
The faculty and fellows in the Division of Pediatric Cardiology have a wide variety of research interests in clinical, translational, and basic investigation related to childhood heart disease.
Research Faculty
Name
|
Areas of Special Interest
|
Piers Barker, MD | Fetal cardiology, cardiac imaging (echo, MRI) |
Richard Justin Boruta, MD | Cardiac imaging, management of feeding and growth following surgery for congenital heart disease |
Cardiac imaging (echo), quality improvement | |
Cardiac imaging (echo, MRI) | |
Michael P. Carboni, MD | Arrhythmias, heart failure/transplantation, multicenter heart failure and transplant studies including PUMPkin network (mechanical cardiac assist devices for children) |
Gregory A. Fleming, MD, MSCI |
Assessment and development of interventional therapies for children with congenital heart disease, perioperative management of infants and children with congenital heart disease requiring surgery |
Heather T. Henderson, MD | Multicenter heart failure and transplant studies including PUMPkin network (mechanical cardiac assist devices for children) |
Kevin D. Hill, MD, MS | Outcomes, drug and device trials, short and long term safety and efficacy of interventions and hemodynamic effects of interventions |
Arrhythmias | |
Sonya Kirmani, MD | Hypertrophic and restrictive cardiomyopathy |
Andrew Paul Landstrom, MD, PhD | Genetic and molecular mechanisms of sudden cardiac arrest in children |
Jennifer Li, MD, MHS | Hypertension, thrombosis, heart failure clinical trials |
Andrew Walker McCrary, MD | Non-invasive assessment of cardiac function in fetal to adult patients with congenital heart disease |
Angelo Milazzo, MD | Fetal cardiology, cardiac imaging (echo) |
Stephen Gary Miller, MD | Fetal cardiology, cardiac imaging (echo) |
Neeta Sethi, MD | Pediatric cardiac imaging, fetal/prenatal cardiology |
Zebulon Zachary Spector, MD | Pediatric and congenital electrophysiology |
Gregory Howard Tatum, MD | Maternal infant bonding in newborn period after prenatal diagnosis of congenital heart disease; qualitative measures of right ventricular function by echocardiography; assessment of pulmonary hypertension by echocardiography; echocardiographic predictors of acute cellular rejection after heart transplantation |
Clinical Research
Participation in trials conducted by the Pediatric Heart Network funded by the National Heart, Lung, and Blood Institute:
- Hypoplastic left heart syndrome
- Kawasaki disease
- Cardiomyopathy
- Marfan syndrome
- Atrioventricular canal
- Fontan
Other clinical trials
- RSV vaccines
- Hypertension
- Heart failure
- Thrombosis
- Supraventricular tachycardia
Cardiac imaging
- 3D echo
- Torsion
- Strain-rate
- MRI
Assessment of various devices to repair congenital cardiac lesions
- Atrial septal defect/patent foramen ovale (device occluder)
- Ventricularr septal defect (device occluder)
- Coarctation of the aorta (stents)
- Cutting balloon for relief of pulmonary artery obstruction
- Percutaneous pulmonary valve
Outcomes assessment following
- Congenital heart surgery
- Radiofrequency ablation
- Heart transplantation
- Implantable Cardioverter Defibrillator (ICD)
Translational/Basic Research
- Stability of Cardiac Response to Pacing
Study of the complex and nonlinear response of the cardiac electrical system to rapid pacing in order to understand and potentially prevent the transition from a stable to an unstable cardiac rhythm utilizing multifaceted experimental and theoretical methods to drive the development of computer models.
Fellow Research
Current and recent fellows have worked on the following projects:
- Glycogen Storage Disease/Pompe Disease clinical trials
- Outcomes of children undergoing surgery in the Society of Thoracic Surgery Congenital Heart Database
- Pediatric hypertension clinical trials
- Endothelial signaling pathways that regulate angiogenesis and vascular remodeling
- Doppler assessment of mesenteric artery flow in Sano vs. BT shunts in HLHS
Clinical Trials
Jennifer Li, MD, Chief of Pediatric Cardiology Research, has several research interests including pediatric hypertension and hyperlipidemia, heart failure in patients with congenital heart disease, thrombosis in patients with congenital heart disease, and enzyme replacement in Pompe disease.
For further information about clinical trials currently being conducted in the Division of Cardiology, please visit Dukechildrens.org.